Inspire Medical Systems Incのファンダメンタルズは比較的非常に健全です。成長の可能性は高いです。バリュエーションは適正価格と評価されています。医療機器 & 備品業界での順位は204中73位です。機関投資家保有率は非常に高いです。過去1か月間に複数のアナリストがホールドと評価し、最高目標株価は61.93とされています。中期的には、株価は下降トレンドと予想されます。同社は過去1か月間、株式市場で好調なパフォーマンスを示しており、これは力強いファンダメンタルズとテクニカルに裏付けられています。株価は支持線と抵抗線の間で横ばい推移しており、レンジ相場でのスイングトレードに適しています。
Inspire Medical Systems Incのスコア
関連情報
業界内順位
73 / 204
全体ランキング
193 / 4564
業種
医療機器 & 備品
サポートラインとレジスタンスライン
会社から関連データがまだ開示されていません。
レーダーチャート
現在
前回値
メディア報道
過去24時間
報道レベル
非常に低い
非常に高い
ネガティブ-
Inspire Medical Systems Incの注目ポイント
強みリスク
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.